Literature DB >> 2838165

Effect of topoisomerase II inhibitors on hyperthermic cytotoxicity.

R L Warters1, L M Brizgys.   

Abstract

Exposure of HeLa or Chinese hamster ovary cells to drugs (novobiocin, nalidixic acid, or oxolinic acid) which inhibit the nuclear enzyme topoisomerase II resulted in a sensitization of both cell lines to hyperthermic heating at 41 and 45 degrees C. Exposure to 0.5 mg/ml novobiocin decreased the reciprocal slope (T0) of the survival curve of HeLa cells heated at 41 and 45 degrees C by a factor of 7.5 and 2.4, respectively. Exposure to 0.5 mg/ml novobiocin decreased the T0 of the survival curve of Chinese hamster ovary cells heated at 41 and 45 degrees C by a factor of 9.8 and 1.8, respectively. Exposure of HeLa cells to 0.5 mg/ml novobiocin delayed thermotolerance development for 1.5 h and depressed by a factor of 27 the survival of cells heated at 45 degrees C once thermotolerance had developed. Coincident with the sensitization to heat-induced cytotoxicity, an enhancement of a heat-induced increase in the total protein mass co-isolating with the nuclei or nuclear matrices from heated cells was observed. A log-linear correlation was found between the reduction in cell survival and the relative nuclear matrix protein mass increase in cells heated at 41 or 45 degrees C in the presence or absence of these drugs. The results are consistent with the notion that exposure to these drugs disrupts the cell's capacity to regulate nuclear structure and composition, and thus enhances heat-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838165

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Increased assembly of cytoskeletal proteins associated with the transformation of human liver cells into fibroblast-like cells.

Authors:  A Tsukamoto; Y Kaneko; K Kurokawa
Journal:  Experientia       Date:  1992-05-15

2.  Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells.

Authors:  J Nordenberg; J Kornfeld; L Wasserman; M Shafran; E Halabe; E Beery; O Landau; A Novogrodsky; Y Sidi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16.

Authors:  J Nordenberg; D Albukrek; T Hadar; A Fux; L Wasserman; A Novogrodsky; Y Sidi
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.